A Case Report of Urinary Tract Infection and Fungemia Due to Pichia ohmeri Complicated with Pulmonary Thromboembolism
Jiang-Jie Sun,Rui Shi,He Huang
DOI: https://doi.org/10.2147/idr.s437788
2024-01-03
Infection and Drug Resistance
Abstract:Jiang-Jie Sun, 1, 2 Rui Shi, 1, 2 He Huang 1, 2 1 Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, 518035, People's Republic of China; 2 Department of Pulmonary and Critical Care Medicine, Shenzhen Second People's Hospital, Shenzhen, Guangdong Province, 518035, People's Republic of China Correspondence: He Huang, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shenzhen University, No. 3002 Sungang Road, Futian District, Shenzhen, Guangdong Province, 518035, People's Republic of China, Email Pichia ohmeri ( P. ohmeri ) is a rare human pathogen known to cause severe conditions such as sepsis, fungemia, endocarditis, and peritonitis, often resulting in high mortality rates. This report presents a case of a febrile 66-year-old male with a urinary tract infection and fungemia caused by P. ohmeri . The patient had additional complications of pulmonary thromboembolism (PTE) and deep venous thrombosis (DVT) in the left lower extremity. Notably, the pathogen was isolated in both urine and blood cultures, an uncommon finding in immunocompetent patients. Treatment with fluconazole was initiated based on the antifungal susceptibility testing (AFST) results. Following treatment, the patient experienced a gradual resolution of fever and urinary tract infection symptoms. Concurrently, anticoagulant therapy was administered for the management of PTE and DVT. The patient was eventually discharged in a stable condition. Keywords: Pichia ohmeri , fungemia, urinary tract infection, pulmonary thromboembolism, deep venous thrombosis Pichia ohmeri ( P. ohmeri ) is an ascomycetous yeast that belongs to the Saccharomycetaceae family. 1 It is a rare and emerging opportunistic pathogen. This pathogen was first isolated from pleural effusion in 1984 and was initially considered a contaminant. The first case of fungemia caused by P. ohmeri was reported in the United States in 1998. 2 The number of reported cases of this pathogen has increased in recent years. Most infected patients have obvious risk factors, including diabetes, malignant tumors, and indwelling catheter. The mortality rate is high, but the appropriate treatment has not yet been determined. 3 In this report, we present a case of urinary tract infection and fungemia caused by P. ohmeri , complicated with pulmonary thromboembolism (PTE) and left lower extremity deep venous thrombosis (DVT), successfully treated with fluconazole. A 66-year-old male patient was admitted to our hospital on June 23, 2021, with a complaint of fever lasting for 7 days. He experienced chills, sweating, and the highest recorded body temperature was 39 degrees Celsius. Additionally, he reported nausea and fatigue but no cough, dyspnea, or chest pain. The patient also presented with oliguria without frequent urination, urgency, or pain. Prior to admission, he had visited the emergency department of a local hospital, where he was diagnosed with a left upper ureteral calculus with left hydronephrosis and infection. Despite receiving imipenem/cilastatin, he continued to have recurrent fevers. A blood culture yielded positive results for fungal growth, and a chest CT scan showed multiple patchy shadows in both lungs, bilateral pleural effusion, and segmental atelectasis in the adjacent lung. Due to concerns about fungal infection leading to fungemia, the patient was transferred to our hospital for further diagnosis and treatment. The patient had a medical history of hypertension and type 2 diabetes mellitus, with poor blood glucose control while currently using insulin. Coarse breath sounds were detected in both lungs, with crackles in the left lung. No other significant findings were observed during the physical examination. An arterial blood gas analysis showed an oxygen partial pressure of 60.0 mmHg without hypercapnia or acidosis. Blood tests indicated an elevated white blood cell count and neutrophilia, along with high levels of inflammatory markers (Procalcitonin [PCT] level: 0.370 ng/mL [normal value <0.094ng/mL], hypersensitive C-reactive protein [hs-CRP]: 62.09 mg/L [normal value 0–5mg/L]). Urinalysis revealed positive leukocytes and glucose (4+). Glycated hemoglobin was 12.5% (normal value 4.2–6.2%), and D-dimer was 10.95 mg/L (normal value <0.55mg/L). Aspergillus galactomannan antigen was measured at 1.10 ug/L (normal value <0.65ug/L), and 1-3-β-D-glucan was 279.50 pg/mL (normal value <60pg/mL). Total IgE and cryptococcal antigen tests showed no abnormalities. Abdominal enhanced CT indicated the presence of multiple stones in both kidneys, a lower left ureteral calculus, and mil -Abstract Truncated-
pharmacology & pharmacy,infectious diseases